Industry News
Researchers discover evidence to support controversial theory of 'buckyball' formation - discovery could affect medical imaging, cancer treatment
Sep 18, 2013
Researchers at the Virginia Tech Carilion Research Institute have reported the first experimental evidence that supports the theory that a soccer ball-shaped nanoparticle commonly called a buckyball is the result of a breakdown of larger structures rather than being built atom-by-atom from the ground up... Read More
Fear drives young cancer patients to needless mastectomies
Sep 17, 2013
After being diagnosed with cancer in one breast, many young women opt to have the other healthy breast removed with a procedure called contralateral prophylactic mastectomy (CPM), despite knowing that it will probably not improve chances of survival, a new study shows. Researchers from the Dana-Faber Cancer Institute published their results in the journal Annals of Internal Medicine... Read More
New marker identified for early diagnosis of lung cancer
Sep 17, 2013
A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research... Read More
Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study
Sep 17, 2013
Results of an EORTC study published in the Journal of Clinical Oncology show that vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma. Vaccination with GM2/KLH-QS-21 stimulates the production of antibodies to the GM2 ganglioside, an antigen expressed by many melanomas... Read More
Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study
Sep 17, 2013
Results of an EORTC study published in the Journal of Clinical Oncology show that vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma. Vaccination with GM2/KLH-QS-21 stimulates the production of antibodies to the GM2 ganglioside, an antigen expressed by many melanomas... Read More
New approach subtypes cancers by shared genetic effects; a step toward personalized medicine
Sep 17, 2013
Cancer tumors almost never share the exact same genetic mutations, a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments... Read More
UNC researchers identify a new pathway that triggers septic shock
Sep 17, 2013
The body's immune system is set up much like a home security system; it has sensors on the outside of cells that act like motion detectors - floodlights - that click on when there's an intruder rustling in the bushes, bacteria that seem suspect. For over a decade researchers have known about one group of external sensors called Toll-like receptors that detect when bacteria are nearby... Read More
Test could identify which prostate cancers require treatment
Sep 16, 2013
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center... Read More
T-rays offer potential for earlier diagnosis of melanoma
Sep 16, 2013
The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist has said... Read More
Tiny diamonds to boost treatment of chemoresistant leukemia
Sep 16, 2013
By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer... Read More
Previous Page Next Page